NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
IceCure Medical Ltd. ICCM
7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$3.4M
▲ 2.7% vs FY2024
EPS · FY25
$-0.24
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-188.8%
Net margin · FY25
-445.6%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.4M
Revenue, FY2025 · full 7-year series below
Revenue
Net income
The company lost 446 cents on every revenue dollar this year.
Per share
USD -0.24
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-188.8%
Return on equity, FY2025
ROE
Operating margin-446.7%
Net margin-445.6%
Return on assets-113.8%
Each USD of equity lost 189 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−2.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+3.1%
−2.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 13.9M
total assets, end of FY2025
Total assetsUSD 13.9M
EquityUSD 9.1M
CashUSD 8.9M
Gross debtUSD 13,000.00
Net debtUSD -8.9M
Current ratio2.61×
The company holds more cash than debt.
History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.24
−0.30
−0.32
−0.46
−0.35
−0.22
−0.33
Dividend / sh $
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
ROE %
−188.8
−160.7
−78.0
−64.8
−60.7
−83.5
−138.3
Shares out B
0.07
0.06
0.05
0.05
0.04
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
26 of 26
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed